Global Small Scale Bioreactors Market Report and Forecast 2024-2032

Global Small Scale Bioreactors Market Report and Forecast 2024-2032


Global Small Scale Bioreactors Market Outlook

The global small scale bioreactors market size was valued at USD 2 billion in 2023, driven by the advent of single-use or disposable bioreactors across the globe. The market size is anticipated to grow at a CAGR of 14.3% during the forecast period of 2024-2032 to achieve a value of USD 6.7 billion by 2032.

Small Scale Bioreactors: Introduction

Small scale bioreactors, often referred to as benchtop bioreactors or mini bioreactors, are compact fermentation and cell culture systems used predominantly in research and development (R&D) settings, pilot studies, and for small-scale production. With capacities generally ranging from a few milliliters up to several liters, these bioreactors provide a controlled environment for the growth of microorganisms, animal cells, or plant cells by maintaining optimal conditions such as temperature, pH, oxygen levels, and agitation.

Key Trends in the Global Small Scale Bioreactors Market

The global small scale bioreactors market is witnessing a flurry of trends influenced by the expanding biotech sector and the ever-increasing R&D investments. Parallelization stands out as a significant trend, with multi-bioreactor systems allowing simultaneous operation under different conditions, maximizing data acquisition, and accelerating process development. The advent of single-use or disposable bioreactors is another notable trend, offering advantages like reduced cross-contamination risks and minimal cleaning requirements, making them ideal for fast-paced R&D environments.

The push towards automation and digitalization has also gained traction, with modern small scale bioreactors being equipped with advanced sensors, controllers, and software platforms, facilitating real-time monitoring and data analytics. This integrates seamlessly with the industry's drive towards Quality by Design (QbD) and Process Analytical Technology (PAT) approaches. Additionally, as cell and gene therapies burgeon, there's a growing demand for bioreactors that can support the cultivation of mammalian and human cells.

Lastly, sustainability concerns have paved the way for eco-friendly designs, focusing on reduced energy consumption and waste. In summary, the global Small Scale Bioreactors market is in a transformative phase, characterized by technological advancements, a focus on efficiency, and adaptability to novel biotechnological challenges.

Global Small Scale Bioreactors Market Segmentation

Market Breakup by Product
  • Reusable Bioreactors
Stainless Steel Bioreactors

Glass Bioreactors
  • Single Use Bioreactors
Market Breakup by Capacity
  • 5 mL-100 mL
  • 100 mL – 250 mL
  • 250 mL – 500 mL
  • 500 mL – 1 L
  • 1 L – 3 L
  • 3 L – 5 L
Market Breakup by Cells
  • Bacterial Cells
  • Yeast Cells
  • Mammalian Cells
Market Breakup by End User
  • Pharmaceutical and Biopharmaceutical Companies
  • CROs and CMOs
  • Academic and Research Institutes
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Small Scale Bioreactors Market Overview

The global small scale bioreactors market is experiencing robust growth, driven by the escalating demands of the biotechnology and pharmaceutical sectors. These compact bioreactors have become instrumental in R&D activities, enabling researchers to efficiently develop and optimize processes in a controlled and scalable environment. A standout feature bolstering the market is the rise of single-use or disposable bioreactors, which offer a streamlined approach to bioprocessing by eliminating extensive cleaning processes and minimizing contamination risks. Furthermore, the integration of advanced automation and digital technologies has enhanced real-time monitoring, data collection, and analytics capabilities, aligning with the industry's shift towards Quality by Design (QbD) principles. The market also benefits from the burgeoning field of cell and gene therapies, which necessitates specialized bioreactors to culture mammalian and human cells.

While developed regions like North America and Europe lead in market share due to their advanced research infrastructure, emerging economies are witnessing rapid growth, fueled by increasing investments in biotechnological research and a push for localized drug production. Despite its promising trajectory, the market faces challenges such as high equipment costs and the need for skilled personnel. Overall, the global Small Scale Bioreactors market, with its confluence of technological innovation and rising biotech applications, is poised for sustained expansion.

Global Small Scale Bioreactors Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Sartorius AG
  • Merck KGaA
  • Lonza Group
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Getinge AB
  • Eppendorf AG
  • Miltenyi Biotec
  • Solaris Biotechnology Srl
  • Infors AG
  • H.E.L Group
  • Lianyungang Bailun Biochemical Technology Co., Ltd
  • Cytiva
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Small Scale Bioreactors Market Overview
3.1 Global Small Scale Bioreactors Market Historical Value (2017-2023)
3.2 Global Small Scale Bioreactors Market Forecast Value (2024-2032)
4 Global Small Scale Bioreactors Market Landscape
4.1 Global Small Scale Bioreactors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Small Scale Bioreactors Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Small Scale Bioreactors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Small Scale Bioreactors Market Segmentation
6.1 Global Small Scale Bioreactors Market by Product
6.1.1 Market Overview
6.1.2 Reusable Bioreactors
6.1.2.1 Stainless Steel Bioreactors
6.1.2.2 Glass Bioreactors
6.1.3 Single Use Bioreactors
6.2 Global Small Scale Bioreactors Market by Capacity
6.2.1 Market Overview
6.2.2 5 mL-100 mL
6.2.3 100 mL – 250 mL
6.2.4 250 mL – 500 mL
6.2.5 500 mL – 1 L
6.2.6 1 L – 3 L
6.2.7 3 L – 5 L
6.3 Global Small Scale Bioreactors Market by Cells
6.3.1 Market Overview
6.3.2 Bacterial Cells
6.3.3 Yeast Cells
6.3.4 Mammalian Cells
6.4 Global Small Scale Bioreactors Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biopharmaceutical Companies
6.4.3 CROs and CMOs
6.4.4 Academic and Research Institutes
6.4.5 Others
6.5 Global Small Scale Bioreactors Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Small Scale Bioreactors Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Small Scale Bioreactors Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Small Scale Bioreactors Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Small Scale Bioreactors Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Small Scale Bioreactors Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Sartorius AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merck KGaA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Lonza Group
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Thermo Fisher Scientific Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Getinge AB
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Eppendorf AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Miltenyi Biotec
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Solaris Biotechnology Srl
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Infors AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 H.E.L Group
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Lianyungang Bailun Biochemical Technology Co., Ltd
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cytiva
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Small Scale Bioreactors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings